[1] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南（2010年版）. 实用肝脏病杂志,2011,14（2）：81-89.
[2] Iloeje UH,Yang HI,Su J,et al. Predicting liver cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology,2006,130:678-686.
[3] Wu CF,Yu MW,Lin CL,et al. Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. Carcinogenesis 2008,29:106-112.
[4] Kao JH,Lin CL. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J Biomed Sci,2008,15:137-145.
[5] Mcmahon BJ. Natural history of chronic hepatitis B Clin. Liver Dis,2010,14:381-396.
[6] Lin CL,Kao JH. The clinical implications of hepatitis B virus genotype:Recent advances. J Gastroenterol Hepatol,2011,26（Suppl 1）:123-130.
[7] Livingst0n SE,Simonetti JP,Mcmahon BJ,et al. Hepatitis B virus genotypes in Alaska native people with hepatocellular carcinoma:preponderance of genotype F. J Infect Dis,2007,195:5-11.
[8] Qu LS,Liu TT,Jin F,et al. Combined pre-S deletion and core promoter mutations related to hepatocellular carcinoma:A nested case-control study in China. Hepatol Res,2011,41:54-63.
[9] Bai X,Zhu Y,Jin Y,et al. Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high-risk for hepatocellular carcinoma. Carcinogenesis,2011,32:63-68.
[10] Liu S,Zhang H,Gu C,et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma:a meta-analysis. J Natl Cancer Inst,2009,101:1066-1082.
[11] Fang ZL,Sabin CA,Dong BQ,et al. The association of HBV core promoter double mutations（A1762T and G1764A）with viral load differs between HBeAg positive and anti-HBe positive individuals:a longitudinal analysis. J Hepatol,2009,50:273-280.
[12] Tong MJ,Blatt LM,Kao JH,et al. Basal core promoter T1762/A1764 and precoreA1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma:a comparison with chronic carriers. Liver Int,2007,27（10）:1356-1363.
[13] Yin JH,Xie JX,Zhang HW,et al. Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma. J Gastroenterol,2010,45:1063-1071.
[14] Mun HS,Lee SA,Kim H,et al. Novel F141L preS2 Mutation of Hepatitis B virus increasing the risk of hepatocellular carcinoma in chronic patients with genotype C infections. J Virol,2011,85（1）:123-132.
[15] Tangkijvanich P,Sa-Nguanmoo P,Mahachai V,et al. A case control study on sequence variations in the enhancer II/core promoter/precore and X genes of hepatitis B virus in patients with hepatocellular carcinoma. Hepatol Int,2010,4:577-584.
[16] Chu CM,Liaw YF. Chronic hepatitis B virus infection acquired in childhood:special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. J Viral Hepat,2007,14:147-152.
[17] Zhang D,Ma SF,Zhang X,et al. Prevalent HBV point mutations and mutation combinations at BCP/preC region and their association with liver disease progression. BMC Infect Dis,2010,10:271.
[18] Fung J,Lao CL,Yuen MY. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B. Atti Infect Ther,2010,8（6）:717-726.
[19] Ozdil B,Cosar AM,Akkiz H,et al. Negative correlation between viral load and HBsAg levels in chronic HBV-infected patients. Arch Virol,2009,154（9）:1451-1455.
（校对：张骏飞） |
